[Federal Register Volume 65, Number 86 (Wednesday, May 3, 2000)]
[Notices]
[Pages 25732-25733]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-10979]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30 DAY-27-00]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-7090. Send written 
comments to CDC, Desk Officer; Human Resources and Housing Branch, New 
Executive Office Building, Room 10235; Washington, DC 20503. Written 
comments should be received within 30 days of this notice.

Proposed Projects

    1. Importation of Etiologic Agents and Packaging and Handling 
Infectious Substances and Select Agents--(0920-0199)--Extension--
Interstate shipment of etiologic agents are regulated by 42 CFR Part 7. 
This rule establishes minimal packaging requirements for all viable 
microorganisms, illustrates the appropriate shipping label, and 
provides reporting instructions regarding damages packages and failure 
to receive a shipment. In recent years the threat of illegitimate use 
of infectious agents has attracted increasing interest from the 
perspective of public health. The Centers for Disease Control and 
Prevention (CDC) is concerned about the possibility that the interstate 
transportation of certain infectious agents could have adverse 
consequences for human health and safety. CDC has already requested 
that all those entities that ship dangerous human infectious agents 
exercise increased vigilance prior to shipment to minimize the risk of 
illicit access to infectious agents. Of special concern are pathogens 
and toxins causing anthrax, botulism, brucellosis, plague, Q fever, 
tularemia, and all agents classified for work at Biosafety Level 4. 
This information collection ensures that selected infectious agents are 
not shipped to parties ill-equipped to handle them appropriately, or 
who do not have legitimate reasons to use them and to implement a 
system whereby scientists and researchers involved in legitimate 
research may continue transferring and receiving these agents without 
undue burdens. Respondents include laboratory facilities such as those 
operated by government agencies, universities, research institutions, 
and commercial entities. This request is for the information collection 
requirements contained in 42 CFR 71.54, 72.3(e) and 72.4 relating to 
the importation and shipment of etiologic agents. Total annual hours 
burden are 1,925.

----------------------------------------------------------------------------------------------------------------
                                                                                      No. of       Avg. burden/
                           CFR Section                                No. of        responses/     response (in
                                                                    respondents     respondent         hrs.)
----------------------------------------------------------------------------------------------------------------
Application for Permit..........................................           2,000               1           20/60

[[Page 25733]]

 
72.3(e).........................................................              50               1            6/60
72.3(f).........................................................             200              10           12/60
72.4............................................................              20               1           12/60
72.6(a).........................................................             100               1          210/60
72.6(d).........................................................             300               2           30/60
72.6(e).........................................................             300               2           10/60
72.6(f).........................................................             300               2           10/60
----------------------------------------------------------------------------------------------------------------


    Dated: April 26, 2000.
Charles W. Gollmar,
Acting Associate Director for Policy, Planning, and Evaluation, Centers 
for Disease Control and Prevention (CDC).
[FR Doc. 00-10979 Filed 5-2-00; 8:45 am]
BILLING CODE 4163-18-P